Aureos CA Growth Fund (EMERGE)
- Active: Active
- Region: Latin America
- Country: Regional
- Sector: Investment funds
- Year: 2006
- Domicile: Mauritius
- Instrument: Fund
- Commitment (MNOK) as of 30.06.2019: 8.6
- Original Commitment (MNOK): 18.9
Aureos Central America Growth Fund (Emerge) offers equity capital and convertible debt financing to the lower end of the SME segment in Central America and the Dominican Republic.
The fund invests exclusively in enterprises that fulfil the criteria as an SME. Increased access to venture capital is intended to allow the enterprises to expand, and thereby recruit more labour. This will in turn produce positive ripple effects throughout Central American economies.
Other investors are CDC, FMO and MIF (Interamerican Development Bank).
Aureos Capital Limited (Aureos)
Aureos Capital Limited (Aureos) was established in July 2001 as a joint venture between the CDC and Norfund. The objective of the joint venture was to create a strong fund manager in a market where there were no strong players, and to enabling the mobilisation of capital to develop countries far beyond what Norfund and CDC could do alone.
Aureos grew to be a global leading SME PE fund manager in emerging and developing markets. By delivering good financial results over time, Aureos succeeded in attracting an increasing proportion of private capital to the funds. Today, ‘non-DFI investors’ (including corporates, family offices, financial institutions and pension funds) is the Fund’s largest investor category. The DFI’s additional role as an investor base of the Aureos funds, as well as owners of the fund manager, diminished accordingly over time. Today, Aureos is incorporated in the Abraaj Capital, a leading private equity investor in emerging markets.
Norfund exited Aureos Capital in 2009, but continues as an investor in the funds.